CAMP4 Therapeutics Corporation CAMP · SEC Filings

website

CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young an...

Price4.69

Market Cap294.32 M

Float46.53 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

8-K

CAMP4 Reports Third Quarter 2026 Financial Results and Corporate Highlights

Nov 5, 2026

8-K

CAMP4 Therapeutics Provides Clinical and Pipeline Updates at September 2026 Analyst Day

Sep 28, 2026

8-K

CAMP4 Therapeutics Reports Q2 2026 Financial Results and Regulatory Progress for CMP-002

Aug 13, 2026

8-K

CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement

Aug 4, 2026

8-K

CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002

Jul 27, 2026

8-K

CAMP4 Therapeutics Corporation Announces Annual Meeting Results and Adoption of 2026 Inducement Plan

Jun 12, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B3

SHARE RESALE REGISTRATION | Offering amount: $50,100,000 | Shares: 32,721,172

Aug 12, 2026

424B5

REGISTERED OFFERING

Dec 18, 2025

424B5

December 2025 ATM | Offering amount: $100,000,000

Dec 1, 2025

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 33,431,131 | Warrants amount: 6,003,758

Nov 25, 2025

424B4

OFFERING | Shares amount: 6,820,000 | Share price: $11.00 | Offering amount: $75,020,000.00

Oct 11, 2024

Registrations

TYPE

HEADLINE

FILED AT

S-3

SHARE RESALE REGISTRATION

Aug 6, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 5, 2026

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Dec 18, 2025

S-3

November 2025 SHELF and ATM

Nov 10, 2025

S-3

SHARE RESALE REGISTRATION

Nov 3, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 27, 2025

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G/A

FMR LLC (Filed by)

Nov 5, 2026

Gold Kelly (Reporting)

Sep 2, 2026

SCHEDULE 13D/A

5AM Ventures VI, L.P. (Filed by)

Aug 31, 2026

Schwab Andrew J. (Reporting)

Aug 31, 2026

Schwab Andrew J. (Reporting)

Aug 26, 2026

Schwab Andrew J. (Reporting)

Aug 21, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Aug 13, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Oct 11, 2024

CORRESP

Form CORRESP - Correspondence

Oct 8, 2024

CORRESP

Form CORRESP - Correspondence

Oct 8, 2024

CORRESP

Form CORRESP - Correspondence

Oct 2, 2024

LETTER

Form UPLOAD - SEC-generated letter

Oct 2, 2024